Jpmorgan Chase & CO Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 5.2% Stake in D.R. Horton, Inc.
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 5.2% in D.R. Horton, Inc.'s common stock as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 6.2% in Eagle Materials Inc.'s common stock as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 7.0% beneficial ownership stake in IAC Inc. as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 5.1% beneficial ownership stake in Regeneron Pharmaceuticals, Inc. as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in Rocket Companies, Inc.'s Class A common stock as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing an 8.9% beneficial ownership stake in Seagate Technology Holdings PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 13.2% Stake in Vicor Corporation
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 13.2% in Vicor Corporation's common stock as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a 5.3% beneficial ownership stake in Western Digital Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 2.7% Passive Stake in WEX Inc.
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 2.7% in WEX Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Amends Beneficial Ownership in Globant S.A., Holding 4.0% Stake
JPMorgan Chase & Co. has filed an amended Schedule 13G, disclosing a 4.0% beneficial ownership stake in Globant S.A. as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a 4.8% beneficial ownership stake in Allegro MicroSystems, Inc. as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 4.9% passive beneficial ownership stake in e.l.f. Beauty, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 10.5% Stake in Warner Music Group
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 10.5% of Warner Music Group Corp.'s Class A Common Stock as of March 31, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, disclosing that its beneficial ownership in Credo Technology Group Holding Ltd has decreased to 3.2% of the outstanding ordinary shares.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 4.3% passive beneficial ownership stake in Analog Devices, Inc. as of February 28, 2025.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Reports Zero Beneficial Ownership in Revance Therapeutics, Inc.
JPMorgan Chase & Co. has filed an amended Schedule 13G, indicating that its beneficial ownership in Revance Therapeutics, Inc. has fallen to 0.0%.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 2.8% Stake in Tenaya Therapeutics
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 2.8% in Tenaya Therapeutics, Inc.'s common stock as of February 28, 2025.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.3% in Trane Technologies PLC as of December 31, 2024.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting a 5.5% beneficial ownership stake in CSX Corporation as of December 31, 2024, indicating a passive investment.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting a 7.4% passive beneficial ownership in REGENXBIO Inc.'s common stock as of December 31, 2024.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 7.9% in Seagate Technology Holdings PLC as of December 31, 2024.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 9.4% Stake in Utz Brands, Inc.
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 9.4% beneficial ownership stake in Utz Brands, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 7.8% Stake in Warner Music Group Class A Common Stock
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.8% of Warner Music Group Corp.'s Class A Common Stock as of December 31, 2024.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a significant beneficial ownership of 6.7% in Western Digital Corporation as of December 31, 2024.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting a 6.4% passive beneficial ownership stake in DR Horton Inc. as of December 31, 2024.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 6.1% in Corpay, Inc.'s common stock as of December 31, 2024.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 6.4% passive beneficial ownership stake in HubSpot, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 8.8% Beneficial Ownership in Otis Worldwide Corporation
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting an 8.8% beneficial ownership stake in Otis Worldwide Corporation as of December 31, 2024.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 7.8% Stake in Carter's, Inc.
JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 7.8% of Carter's, Inc. common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: JPMorgan Chase & Co. Discloses 6.0% Passive Stake in IAC Inc.
JPMorgan Chase & Co. has filed an amended Schedule 13G, disclosing a 6.0% beneficial ownership stake in IAC Inc. as of December 31, 2024.